Professor in Neurochemistry, Neurochemistry Laboratory, Amsterdam UMC
BIOGRAPHY
Speaker
Event Date & Time
Date: November 19, 2025
Time: 5:00 AM (PST), 8:00 AM (EST), 2:00 PM (CET)
Abstract
Fluid biomarkers for Alzheimer’s disease (AD) have advanced rapidly during the past several years driven by breakthroughs including development of ultrasensitive and multiplexing technologies and high specificity antibodies. Blood-based biomarkers for AD are being implemented in clinical practice. Fluid biomarkers will play an even more prominent role in clinical care in the future for disorders affecting cognition: for diagnosis, prognosis, treatment monitoring, and treatment development. Multiple fluid biomarkers will need to be measured to capture the complexity of disease mechanisms; measuring diverse pathologies that lead to dementia, and understanding heterogeneity between patients. I will present and discuss these options and discuss recently generated results on the in-house custom Olink Focus 42 Dementia panel and newly available Target 48 Neurodegeneration panels. The focus will be the use for dementia diagnosis and for use in treatments.
Learning Objectives
- Understand the expanding role of fluid biomarkers in diagnosing, monitoring, and treating Alzheimer’s disease and other dementias.
- Discover how multiplexing technologies such as Olink’s Proximity Extension Assay enable sensitive protein measurement to support uncovering diverse disease mechanisms.
- Learn how biomarker panels such as Olink Focus and new Target 48 Neurodegeneration contribute to understanding patient heterogeneity and supporting treatment development.
Webinars will be available for unlimited on-demand viewing after live event.
You May Also Like
OCT 07, 2025 | 7:00 AM
The analysis of protein behavior and protein interactions is central in drug research. In this web seminar, we will show you how the automation of protein purification and downstream thermal...
OCT 07, 2025 | 11:00 AM
Mass Photometry (MP) and Macro Mass Photometry (MMP) are complementary, label-free techniques that analyze biomolecules and therapeutic vectors directly in solution with single-particle reso...
OCT 08, 2025 | 9:00 AM
Cell counting is a fundamental step in many workflows, including cell culture, cell analysis, transfection, single cell sequencing, and cell therapy. Automated cell counters have improved th...
OCT 09, 2025 | 8:07 AM
At Evotec, we turn great science into real-world medicines; faster, smarter and at exceptional quality. We partner with biotech, pharma and academic institutions to deliver from disease unde...
OCT 14, 2025 | 10:00 AM
Stem cells and organoids are revolutionising medical advancements. The journey from stem cell research to translational medicine is extensive, and maintaining quality throughout development...
OCT 14, 2025 | 9:00 AM
Current guidelines by the International Myeloma Working Group and College of American Pathologists recommend performing serum protein electrophoresis (SPEP) and serum free light chain (sFLC)...
Loading Comments...